A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial
Imperial College London · Hôpital Privé Jacques Cartier · +13 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
560
total citations
- FWCI
- 110.55
- Percentile
- 100%
- References
- 39
Citations per year
Authors
17Topics & keywords
Topics
Keywords
- Medicine
- Everolimus
- Myocardial infarction
- Cardiology
- Internal medicine
- Clinical endpoint
- Stent
- Coronary artery disease
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.